NBP
NASDAQ
$1.71
NovaBridge Biosciences. (NBP)
NovaBridge Biosciences, a biotech company, focuses on the development of immuno-oncology agents for the treatment of cancer in the United States. The company is headquartered in Rockville, Maryland.
Sector:
Healthcare
Industry:
Biotechnology
Buy
Target: $8 (+367.84%)
Market Cap
$151M
P/B Ratio
0.94
FCF 5Y CAGR
+34.86%
Beta (5Y)
0.91
Price Chart
Valuation
Market Cap$151M
Forward P/E2.68
P/S25.39
P/B0.94
Profitability
EBITDA-$12M
EPS-$0.16
Financial Health
Debt-to-Equity1.7%
Growth & Risk
Revenue 5Y CAGR-12.46%
FCF 5Y CAGR+34.86%
Beta (5Y)0.91
Sharpe Ratio0.75